Literature DB >> 22089265

Severe ovarian hyperstimulation syndrome after letrozole-gonadotropin stimulation: a case report.

Jayeon Kim1, Anne Z Steiner, Marc Fritz, Jennifer E Mersereau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22089265      PMCID： PMC3270136          DOI： 10.1007/s10815-011-9676-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  9 in total

Review 1.  Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures.

Authors:  M A Aboulghar; R T Mansour
Journal:  Hum Reprod Update       Date:  2003 May-Jun       Impact factor: 15.610

2.  GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation.

Authors:  Kutluk Oktay; Ilgın Türkçüoğlu; Kenny A Rodriguez-Wallberg
Journal:  Reprod Biomed Online       Date:  2010-03-06       Impact factor: 3.828

3.  Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.

Authors:  Kutluk Oktay; Ariel Hourvitz; Gulnaz Sahin; Ozgur Oktem; Bradley Safro; Aylin Cil; Heejung Bang
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

4.  Effect of estrogen deprivation on the reproductive physiology of male and female primates.

Authors:  G Shetty; H Krishnamurthy; H N Krishnamurthy; S Bhatnagar; R N Moudgal
Journal:  J Steroid Biochem Mol Biol       Date:  1997-04       Impact factor: 4.292

5.  Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial.

Authors:  A Badawy; A Elnashar; M Totongy
Journal:  J Obstet Gynaecol       Date:  2010       Impact factor: 1.246

Review 6.  Prevention and management of ovarian hyperstimulation syndrome.

Authors:  Nikos F Vlahos; Odysseas Gregoriou
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

Review 7.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

8.  Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups.

Authors:  R H Asch; H P Li; J P Balmaceda; L N Weckstein; S C Stone
Journal:  Hum Reprod       Date:  1991-11       Impact factor: 6.918

Review 9.  Ovarian hyperstimulation syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2008-11       Impact factor: 7.329
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.